Ehrenberg L - Search Results

1

Dosimetry of ethylene oxide in the rat by quantitation of alkylated histidine in hemoglobin.

Osterman-Golkar S, Farmer PB, Segerbäck D, Bailey E, Calleman CJ, Svensson K, Ehrenberg L. Osterman-Golkar S, et al. Among authors: ehrenberg l. Teratog Carcinog Mutagen. 1983;3(5):395-405. doi: 10.1002/1520-6866(1990)3:5<395::aid-tcm1770030502>3.0.co;2-d. Teratog Carcinog Mutagen. 1983. PMID: 6139887

2

Tissue doses of ethylene oxide in cigarette smokers determined from adduct levels in hemoglobin.

Törnqvist M, Osterman-Golkar S, Kautiainen A, Jensen S, Farmer PB, Ehrenberg L. Törnqvist M, et al. Among authors: ehrenberg l. Carcinogenesis. 1986 Sep;7(9):1519-21. doi: 10.1093/carcin/7.9.1519. Carcinogenesis. 1986. PMID: 3742724

3

Alkylation of macromolecules for detecting mutagenic agents.

Ehrenberg L, Osterman-Golkar S. Ehrenberg L, et al. Teratog Carcinog Mutagen. 1980;1(1):105-27. doi: 10.1002/tcm.1770010111. Teratog Carcinog Mutagen. 1980. PMID: 6119796 Review.

4

Evaluation of genetic risks of alkylating agents. III. Alkylation of haemoglobin after metabolic conversion of ethene to ethene oxide in vivo.

Ehrenberg L, Osterman-Golkar S, Segerbäck D, Svensson K, Calleman CJ. Ehrenberg L, et al. Mutat Res. 1977 Nov;45(2):175-84. doi: 10.1016/0027-5107(77)90017-3. Mutat Res. 1977. PMID: 593285

5

Monitoring and risk assessment by means of alkyl groups in hemoglobin in persons occupationally exposed to ethylene oxide.

Calleman CJ, Ehrenberg L, Jansson B, Osterman-Golkar S, Segerbäck D, Svensson K, Wachtmeister CA. Calleman CJ, et al. Among authors: ehrenberg l. J Environ Pathol Toxicol. 1978 Nov-Dec;2(2):427-42. J Environ Pathol Toxicol. 1978. PMID: 739221

6

Misincorporation of alkylated amino acids into hemoglobin--a possible source of background alkylations.

Kautiainen A, Osterman-Golkar S, Ehrenberg L. Kautiainen A, et al. Among authors: ehrenberg l. Acta Chem Scand B. 1986 Jul;40(6):453-6. doi: 10.3891/acta.chem.scand.40b-0453. Acta Chem Scand B. 1986. PMID: 3766015

7

Covalent binding of reactive intermediates to hemoglobin as an approach for determining the metabolic activation of chemicals--ethylene.

Osterman-Golkar S, Ehrenberg L. Osterman-Golkar S, et al. Among authors: ehrenberg l. Drug Metab Rev. 1982;13(4):647-60. doi: 10.3109/03602538209011090. Drug Metab Rev. 1982. PMID: 6751752 Review. No abstract available.

8

Dosimetry of electrophilic compounds by means of hemoglobin alkylation.

Osterman-Golkar S, Ehrenberg L. Osterman-Golkar S, et al. Among authors: ehrenberg l. Annu Rev Public Health. 1983;4:397-402. doi: 10.1146/annurev.pu.04.050183.002145. Annu Rev Public Health. 1983. PMID: 6860448 No abstract available.

9

Evaluation of genetic risks of alkylating agents. II. Haemoglobin as a dose monitor.

Osterman-Golkar S, Ehrenberg L, Segerbäck D, Hällström I. Osterman-Golkar S, et al. Among authors: ehrenberg l. Mutat Res. 1976 Jan;34(1):1-10. doi: 10.1016/0027-5107(76)90256-6. Mutat Res. 1976. PMID: 1250243

10

Evaluation of genetic risks of alkylating agents IV. Quantitative determination of alkylated amino acids in haemoglobin as a measure of the dose after-treatment of mice with methyl methanesulfonate.

Segerbäck D, Calleman CJ, Ehrenberg L, Löfroth G, Osterman-Golkar S. Segerbäck D, et al. Among authors: ehrenberg l. Mutat Res. 1978 Jan;49(1):71-82. doi: 10.1016/0027-5107(78)90079-9. Mutat Res. 1978. PMID: 202871 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters